Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer-Reference-Cited by-同舟云学术

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

Published:2010-05 Issue:2 Volume:68 Page:240-247
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Mylonakis N.,Athanasiou A.,Ziras N.,Angel J.,Rapti A.,Lampaki S.,Politis N.,Karanikas C.,Kosmas C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. World Health Organization. Deaths by cause, sex and mortality stratum. The World Health Report; 2004.

2. Cancer;World Health Organization,2006

3. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study;Crinò;JCO,1997

4. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma;Abratt;Semin Oncol,1997

5. A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting;Hussain;Oncol Rep,2008

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07

3. From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs;Current Pharmaceutical Design;2023-06

4. Nanomedicine Applications in Cancer Treatment;Handbook of Cancer and Immunology;2023

5. Advanced Nanomaterials for the Diagnosis and Treatment of Renal Cell Carcinoma;Advanced NanoBiomed Research;2022-12-21